Inmode Ltd
NASDAQ:INMD
Gross Margin
Inmode Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| IL |
|
Inmode Ltd
NASDAQ:INMD
|
1.3B USD |
80%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
228B USD |
56%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176.8B USD |
67%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
147.9B USD |
68%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
142B USD |
64%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.6B USD |
66%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
65.6B USD |
45%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
56.1B EUR |
38%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
42.3B USD |
79%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
286.9B CNY |
64%
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
36.4B USD |
42%
|
Inmode Ltd
Glance View
InMode Ltd., founded in 2008, has emerged as a dynamic player in the field of minimally invasive aesthetic medical treatments. Born during a period where the health and beauty sectors were experiencing rapid technological innovation, the company quickly carved a niche for itself by addressing a clear market need: the rising demand for non-surgical procedures. At its heart, InMode merges the precision of medical technology with the principles of aesthetic enhancement. Its primary offerings revolve around radio-frequency-based devices that healthcare providers use to achieve results that traditionally required more invasive techniques. This includes skin tightening, fat reduction, and body contouring solutions, all tailored to meet the growing consumer appetite for treatments that carry less downtime and risk compared to conventional surgery. The company monetizes its expertise by manufacturing and selling these state-of-the-art devices to a diverse group of users, ranging from dermatologists and plastic surgeons to aesthetic practices. InMode's revenue streams are bolstered by not only the direct sale of these devices but also by ongoing client relationships through service agreements and consumable products that are essential for their machine operation. It is a model that ensures continuous engagement with their clients, providing both stability and growth in revenue. By focusing on innovation and efficacy, InMode has successfully captured a significant share of the aesthetic medical market, embodying a business strategy that combines cutting-edge technology with practical solutions to consumer needs.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Inmode Ltd's most recent financial statements, the company has Gross Margin of 80.3%.
You don't have any saved screeners yet